Most Recent
GSK loses patent infringement appeal over slow-release Panadol
Intellectual Property 2018-05-11 9:32 pm By Christine Caulfield Melbourne
A full bench of the Federal Court has dismissed an appeal by drug giant GlaxoSmithKline in a patent infringement case it brought over planned generic versions of its sustained-release Panadol.
  1. Pages:
  3. 1
  5. 21
  6. 22
  7. 23
  8. 24
  9. 25
  10. 26
  11. 27
  12. 28